News

AstraZeneca stops paying for German doctors to attend conferences

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2949 (Published 10 May 2011) Cite this as: BMJ 2011;342:d2949
  1. Ned Stafford
  1. 1Hamburg

The UK’s new Bribery Act, which took effect in April, seems to be having a knock on effect in Germany, where at least one German subsidiary of a UK based drug company has announced it will no longer pay for doctors to attend international conferences.

Kai Richter, medical director for AstraZeneca Deutschland, told the Financial Times Deutschland that beginning in the second half of the year the company will not cover the cost of hotels and travel or conference fees for doctors attending medical science events.

Dr Richter was not quoted in the article as specifically saying the decision was taken on account …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe